Citius Pharmaceuticals, Inc. (CTXR) Reports In-Line Q3 EPS

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• SanDisk upgraded at JPMorgan after investor day; shares climb